JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
AXSM Financials - Axsome Therapeutics Income & Cash Flow | Ledgeburg
AXSM - Axsome Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary AXSM Stock
Financials
Financials AXSM Stock
Loading...
Loading...
Income Statement
Income Statement AXSM Stock
Balance Sheet
Balance Sheet AXSM Stock
Cash Flow Statement
Cash Flow Statement AXSM Stock
Loading...
Loading...
Home
Stocks
Axsome Therapeutics, Inc. (AXSM)
Financials
Financials of AXSM
Loading...
Loading...
Loading...
Loading...
Revenue
$638.496M
Operating Income
$-166.762M
Net Income
$-183.174M
Share Count (Basic)
49.747178M
Operating Cash Flow
$-93.405M
Free Cash Flow
$-93.885M
Cash And Short-Term Equivalents
$322.933M
Total Debt
$187.746M
Annual
Quarterly
Revenue $USD
0
200M
400M
600M
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
50M
100M
150M
200M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-300M
-250M
-200M
-150M
Annual
Quarterly
Margins
Gross
Operating
Net
-80%
-60%
-40%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-60M
-50M
-40M
-30M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-50%
-40%
-30%
-20%
-10%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26